Teresa Hastings

University of Pittsburgh, Pittsburgh, PA, United States 
Neuroscience Biology, Pathology
"Teresa Hastings"
Mean distance: 26716.5
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bucher ML, Barrett CW, Moon CJ, et al. (2020) Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson's disease. Npj Parkinson's Disease. 6: 34
Van Laar VS, Chen J, Zharikov AD, et al. (2020) α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo. Redox Biology. 37: 101695
Rocha EM, De Miranda BR, Castro S, et al. (2019) LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease. Neurobiology of Disease. 104626
Van Laar VS, Otero PA, Hastings TG, et al. (2018) Potential Role of Mic60/Mitofilin in Parkinson's Disease. Frontiers in Neuroscience. 12: 898
Di Maio R, Hoffman EK, Rocha EM, et al. (2018) LRRK2 activation in idiopathic Parkinson's disease. Science Translational Medicine. 10
Di Maio R, Barrett PJ, Hoffman EK, et al. (2016) α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease. Science Translational Medicine. 8: 342ra78
Van Laar VS, Berman SB, Hastings TG. (2016) Mic60/mitofilin overexpression alters mitochondrial dynamics and attenuates vulnerability of dopaminergic cells to dopamine and rotenone. Neurobiology of Disease. 91: 247-61
Zharikov AD, Cannon JR, Tapias V, et al. (2015) shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model. The Journal of Clinical Investigation
Hauser DN, Dukes AA, Mortimer AD, et al. (2013) Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4. Free Radical Biology & Medicine. 65: 419-27
Hauser DN, Hastings TG. (2013) Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism Neurobiology of Disease. 51: 35-42
See more...